Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Berglund LM, Lyssenko V, Ladenvall C, Kotova O, Edsfeldt A, Pilgaard K, et al
Case reports have also indicated beneficial effects of KD in epileptic encephalopathies such as Lafora body disease (69), early infantile epileptic encephalopathy (70), LandauKleffner syndrome (71), subacute sclerosing panencephalitis (72), adenylosuccinate lyase deficiency (73), juvenile myoclonic epilepsy (74), CDKL5 encephalopathy (75), infantile epilepsy with migrating focal seizures (76), childhood absence epilepsy (77), and epileptic encephalopathy with continuous spike-and-wave during sleep (78)
Liraglutide exemplifies this approach through specific molecular modifications
Peer review Peer review information Nature Immunology thanks Philipp Henneke and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
US$ 27.32
US$ 21.04
US$ 20.55
US$ 25.81
US$ 27.56
US$ 22.59
US$ 21.64
US$ 26.71
US$ 28.33
